89049 Chct for mal hyperthermia
Also known as: contracture test malignant hyperthermia, malignant hyperthermia susceptibility test
Contracture test on muscle tissue for assessment of malignant hyperthermia susceptibility using specialized laboratory techniques.
Clinical Context
Diagnostic test on muscle biopsy for malignant hyperthermia susceptibility; performed in patients with family history or prior anesthetic complications.
RVU Breakdown
| Work RVU | 1.37 |
| Practice Expense RVU | 9.06 |
| Malpractice RVU | 0.18 |
| Total RVU | 10.61 |
Est. Medicare Payment
National estimate based on 2026 CMS PFS Conversion Factor ($33.40). Actual payment varies by locality (GPCI adjustment).
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.